259 related articles for article (PubMed ID: 36763119)
21. Long-term outcome of ultrasound-guided focused ultrasound ablation for gestational trophoblastic neoplasia in the cesarean scar: a case report.
Qu D; Chen Y; Jiang J; Shi Q; Zhou H; Wang Z
BMC Womens Health; 2022 Dec; 22(1):522. PubMed ID: 36522625
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
23. Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease?
Sefidbakht S; Hosseini F; Bijan B; Hamedi B; Azizi T
Eur J Radiol; 2017 Mar; 88():71-76. PubMed ID: 28189211
[TBL] [Abstract][Full Text] [Related]
24. State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.
Elias KM; Berkowitz RS; Horowitz NS
J Natl Compr Canc Netw; 2019 Nov; 17(11):1396-1401. PubMed ID: 31693988
[TBL] [Abstract][Full Text] [Related]
25. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
26. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
27. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Gadducci A; Lanfredini N; Cosio S
Gynecol Endocrinol; 2015; 31(9):673-8. PubMed ID: 26288335
[TBL] [Abstract][Full Text] [Related]
28. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
Albright BB; Myers ER; Moss HA; Ko EM; Sonalkar S; Havrilesky LJ
Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
[TBL] [Abstract][Full Text] [Related]
29. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic disease: an overview.
Monchek R; Wiedaseck S
J Midwifery Womens Health; 2012; 57(3):255-9. PubMed ID: 22587615
[TBL] [Abstract][Full Text] [Related]
31. Pathology of gestational trophoblastic disease (GTD).
Kaur B
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():3-28. PubMed ID: 34219021
[TBL] [Abstract][Full Text] [Related]
32. Gestational trophoblastic disease: a spectrum of radiologic diagnosis.
Green CL; Angtuaco TL; Shah HR; Parmley TH
Radiographics; 1996 Nov; 16(6):1371-84. PubMed ID: 8946542
[TBL] [Abstract][Full Text] [Related]
33. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
34. [Sonographic diagnosis of gestational trophoblastic disease in early pregnancy].
Visca E; Vökt CA; Tercanli S
Ther Umsch; 2008 Nov; 65(11):657-61. PubMed ID: 18979428
[TBL] [Abstract][Full Text] [Related]
35. Current chemotherapeutic options for the treatment of gestational trophoblastic disease.
Braga A; Paiva G; Cattai CJ; Elias KM; Horowitz NS; Berkowitz RS
Expert Opin Pharmacother; 2023 Feb; 24(2):245-258. PubMed ID: 36399723
[TBL] [Abstract][Full Text] [Related]
36. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
37. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
38. Role of hysteroscopy and ultrasound in early identification of post-molar gestational trophoblastic neoplasia.
Subbaiah M; Raj A; Durairaj J; Keepanasseril A
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():33-37. PubMed ID: 32920420
[TBL] [Abstract][Full Text] [Related]
39. Gestational trophoblastic disease: pictorial review.
Jain KA
Ultrasound Q; 2005 Dec; 21(4):245-53. PubMed ID: 16344728
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
